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Abstract
Fo ¨rster resonance energy transfer (FRET) microscopy is frequently used to study protein interactions and conformational
changes in living cells. The utility of FRET is limited by false positive and negative signals. To overcome these limitations we
have developed Fluorescence Polarization and Fluctuation Analysis (FPFA), a hybrid single-molecule based method
combining time-resolved fluorescence anisotropy (homo-FRET) and fluorescence correlation spectroscopy. Using FPFA,
homo-FRET (a 1–10 nm proximity gauge), brightness (a measure of the number of fluorescent subunits in a complex), and
correlation time (an attribute sensitive to the mass and shape of a protein complex) can be simultaneously measured. These
measurements together rigorously constrain the interpretation of FRET signals. Venus based control-constructs were used
to validate FPFA. The utility of FPFA was demonstrated by measuring in living cells the number of subunits in the a-isoform
of Venus-tagged calcium-calmodulin dependent protein kinase-II (CaMKIIa) holoenzyme. Brightness analysis revealed that
the holoenzyme has, on average, 11.961.2 subunit, but values ranged from 10–14 in individual cells. Homo-FRET analysis
simultaneously detected that catalytic domains were arranged as dimers in the dodecameric holoenzyme, and this paired
organization was confirmed by quantitative hetero-FRET analysis. In freshly prepared cell homogenates FPFA detected only
10.261.3 subunits in the holoenzyme with values ranging from 9–12. Despite the reduction in subunit number, catalytic
domains were still arranged as pairs in homogenates. Thus, FPFA suggests that while the absolute number of subunits in an
auto-inhibited holoenzyme might vary from cell to cell, the organization of catalytic domains into pairs is preserved.
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Introduction
In cells, proteins rarely function individually; typically they
interact with other proteins to mediate cellular processes.
Determining the structure and dynamics of protein complexes in
cells requires noninvasive high-resolution spatial and temporal
methods, such as Fo ¨rster resonance energy transfer (FRET)
microscopy [1,2,3,4,5,6]. Because the efficiency of FRET is
inversely proportional to the 6
th power of the distance separating
fluorescent donors and acceptors [2,3,7], FRET has been used to
study protein interactions in cells. Energy transfer between
proteins tagged with either the same fluorophore (homo-FRET
[8,9,10,11,12]) or spectrally distinct fluorophores (hetero-FRET
[2,3]) can be monitored using time correlated single photon
counting (TCSPC [13]) to measure dynamic changes in fluores-
cence polarization or intensity respectively. However, the absence
of FRET does not necessarily mean that proteins are not in a
complex because the distance separating fluorophores in a
complex may be larger than 10 nm (or their dipole orientation
may be unfavorable). Similarly, a positive FRET signal may arise
from non-specific FRET caused by protein over-expression rather
than complex formation. These limitations are illustrated in
figure 1A, in which six possible arrangements of a fluorescent
protein-tagged subunit are depicted. In this diagram homo-FRET
is expected for protein complexes if their attached fluorophores
(yellow cylinders) are in close proximity. Thus, homo-FRET would
not be observed for examples 1, 3, and 5 (even though example 3
is a dimer and example 5 is a hexamer), but FRET should be
observed in examples 2 and 4. Furthermore, FRET measurements
alone cannot differentiate between example 2 (a dimer) and
example 4 (a hexamer). Homo-FRET should also be observed for
example 6, monomers in close proximity. One potential way to
differentiate all six subunit arrangements depicted in figure 1A is
to measure homo-FRET and Fluorescence Correlation Spectros-
copy (FCS) simultaneously.
Unlike FRET, FCS monitors the motion of fluorophore-tagged
proteins, not their proximity [14,15,16,17]. In a FCS experiment
temporal fluctuations of fluorescence intensity emanating from a
small volume (typically less than 1 fl) are measured as individual
protein complexes traverse the observation volume [16,17]. Auto-
and cross-correlation analysis [16,17,18] of theses fluctuations can
then reveal the average number of fluorescent molecules in the
observation volume, ,N.. Molecular brightness, the average
number of photon counts per second per fluctuating molecule
(cpsm), is obtained by taking the ratio ,k./,N., where ,k. is
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e38209Figure 1. Fluorescence Polarization and Fluctuation Analysis: A method for studying the structure of protein complexes. (A) Six
possible structures for a hypothetical protein (Blue hexagon) tagged with Venus (yellow cylinder). Example 1 depicts monomers. Examples 2 and 3
depict dimers. Attached Venus molecules are in close apposition for example 2 but not for example 3. Examples 4 and 5 depict hexamers. Pairs of
attached Venus molecules are in close apposition for example 4 but not for example 5. Example 6 depicts monomers that are confined to a sub-
compartment (dashed line) where they are expressed at a high concentration. (B) Schematic for microscope to measure FPFA. (C) Micro-time data
measured for a homogenate prepared from cells expressing Venus monomers are used to calculate fluorescence lifetime histograms for photons
detected by either the parallel or perpendicular hybrid-detectors as a function of time after the laser excitation pulse (left panel). These two decay
curves are then used to calculate the time-resolved anisotropy (right panel top), or fluorescence lifetime (right panel bottom) of Venus monomers.
Red dashed lines show fitting to a single exponential model. (D) Macro-time data measured for a homogenate prepared from cells expressing Venus
monomers are used to calculate auto- and cross-correlation functions for photons detected in the parallel and perpendicular hybrid-detectors. A
single diffusible-component 3-D Gaussian model was used to fit the cross-correlation (red dashed line), and to estimate the correlation time and the
average number of molecules in the observation volume. The excitation power used was 10.2 mW.
doi:10.1371/journal.pone.0038209.g001
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to measure the brightness of free fluorophore, the molecular
brightness, can be used to calculate the Normalized Brightness - the
average number of fluorophores in a protein complex. If each
subunit is tagged with only a single fluorophore, the normalized
brightness will reflect the number of subunits in a complex. This is
called Brightness Analysis [19]. In addition, FCS can also determine
the average amount of time a protein complex remains in the
observation volume [17]; a value related to the lateral diffusion
coefficient of the complex, itself a function of viscosity, mass and
hydrodynamic volume (and hence the conformation of the
complex). Another technical advantage of FCS analysis is that
single molecule fluctuations in the fluorescent intensity can only be
observed at very low fluorophore concentrations (typically nano-
molar) [17], thus, many of the problems associated with over
expression of exogenous proteins cannot exist in successful FCS
experiments. By considering both the presence (or absence) of
homo-FRET, as well as the normalized brightness, all 6 examples
depicted in figure 1A could be differentiated. Furthermore, often
these interpretations could be corroborated using the lateral
diffusion time, an additional parameter measured.
While FRET and FCS are usually considered alternative
approaches for studying protein complexes [20], figure 1A
illustrates that combining them could be advantageous. New
instrumentation for TCSPC can now record both micro-time (the
elapsed time between photon detection and the laser excitation
pulse) and macro-time (the elapsed time between the start of an
experiment and when an individual photon is detected) [13,21].
This technology enables combining FCS (based on macro-time
data) and either hetero- or homo-FRET (which both use micro-
time data) with high photon efficiency. While combining hetero-
FRET and FCS is problematic (donor emission may bleed into the
acceptor signal, and hetero-FRET itself will cause reciprocal
intensity fluctuations in donor and acceptor channels) [20],
combining homo-FRET and FCS is more straightforward
(because only a single fluorophore is used). An additional benefit
of combining homo-FRET and FCS is that spectral bandwidth for
fluorophore excitation and emission is kept narrow enabling the
use of other fluorophores in more complicated multiplexed
experiments.
Here we describe a new method, Fluorescence Polarization and
Fluctuation Analysis (FPFA), that combines Fo ¨rster resonance
energy transfer microscopy (FRET) [1,2,3,4,5,6] and Fluorescence
Correlation Spectroscopy (FCS) [14,15,16,17] as a tool to study
the structure of protein complexes inside living cells. We developed
this method specifically to characterize the structure of the
calcium-calmodulin dependent protein kinase-II (CaMKII) holo-
enzyme under physiological conditions. CaMKII is an excellent
example of a protein whose function depends on protein-protein
interactions. CaMKII subunits assemble to form a multimeric
kinase involved in memory and synaptic modulation [22,23]. The
number of subunits that comprise the holoenzyme is uncertain
with estimates ranging from 3 to 14 [24,25,26,27,28,29,30]. In
cells the kinase is transiently activated in response to a rise in
intracellular calcium. Calcium binds to calmodulin (CaM) to form
calcium/calmodulin (Ca
2+/CaM) [23], and Ca
2+/CaM in turn
binds to the regulatory domain of CaMKII. Ca
2+/CaM binding to
CaMKII is thought to trigger a large conformational change that
opens the substrate-binding site on the catalytic domain [30].
Unlike most other biological calcium sensors, CaMKII is sensitive
to the frequency of calcium spikes [31]. This unique ability is
thought to be an emergent feature of its holoenzyme organization
[32], and is thought to play a role in memory storage [22]. Little is
known about the structure or stoichiometry of the holoenzyme
under physiological conditions, in part because few methods exist
to monitor the structure of protein complexes in cells.
CaMKII monomers have three domains, the N-terminal
catalytic domain, a regulatory domain, and a C-terminal
association domain responsible for holoenzyme oligomerization
[23,33]. In the auto-inhibited holoenzyme, catalytic domains are
thought to dimerize [10,30,34], resulting in a holoenzyme
structure with multiple catalytic domain pairs distributed around
a central association domain core. X-ray crystallography was first
to indicate that isolated CaMKIIa catalytic domains are arranged
as dimers [34], but the validity of this conclusion is controversial,
as this dimeric structure was not observed in X-ray data sets for
isolated catalytic domains from several other CaMKII isoforms
[30]. Nonetheless, analytic ultracentrifugation of isolated catalytic
domains from multiple isoforms did detect catalytic domain
dimerization [30], as did homo-FRET experiments with fluores-
cent protein-tagged CaMKIIa in hippocampal neurons [10].
Catalytic domain pairing was not observed in a recent crystal
structure of a mutated CaMKIIb7 holoenzyme. In this new model
for the holoenzyme structure individual catalytic domains are
docked onto the central association domain core as monomers to
form a compact holoenzyme structure [35]. Because Ca
2+/CaM
binding sites on the regulatory domain are inaccessible in this
compact structure, it was proposed that a more extended auto-
inhibited structure must also exist to allow for activation. Mutation
in the CaMKII regulatory domain (TT305/306DD for the a
isoform) are known to prevent Ca
2+/CaM from binding to
CaMKII [36], and based on this new model are now predicted to
also disrupt the docking of catalytic domains to the association
domain core [35]. Thus it is possible that catalytic domains might
form pairs after they un-dock from the association domain core. It
should be noted that unlike most CaMKII isoforms, the
CaMKIIb7 isoform had dramatically reduced levels of catalytic
activity under physiological conditions [35,37]. Thus, it is unclear
if this new model for the intact CaMKIIb7 holoenzyme reflects the
structure of active CaMKII isoforms in cells.
In this study we develop a new method for characterizing
protein complexes in living cells, FPFA. We first validate this
method with two sets of Venus [38] based control constructs, and
then apply FPFA to simultaneously measure the number of
subunits in the CaMKIIa holoenzyme in cells, as well as the
organization of its catalytic domains.
Results
The experimental setup used for linear-polarized two-photon
excitation of fluorophores in a small focal volume is shown in
figure1B.Bothmicro-andmacro-timesofemittedphotonsdetected
through orthogonally oriented polarization pathways (parallel and
perpendicular) were recorded. Calibration experiments with fluo-
resceinandVenusmonomerswereusedtoidentifyexcitationpowers
in vitro where bleaching of Venus was not detected, and to then
estimatethevolumeanddimensionsofourobservationvolumeunder
these conditions (see materials and methods). For in vitro measure-
ments laser powers ranging from 9.0–10.2 mW were used. Time-
resolved anisotropy (TRA) and lifetime were calculated from
histograms of parallel and perpendicular detector micro-times
(Fig 1C), while polarization corrected correlation times and
brightness were calculated by fitting the cross-correlation of these
detectors macro-time signals[39] (Fig1D).
Validation of FPFA
FPFA was validated using 6 fluorescent oligomers composed of
between 1 and 6 concatenated Venus molecules (V1–V6). Venus,
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[38], and has a Fo ¨rster distance of 5.3 nm [40] supporting efficient
homo-FRET. To avoid nonspecific aggregation, a monomeric
variant of Venus was used in all experiments [41]. Immunoblot
analysis using a GFP specific antibody confirmed that the
molecular weight of these constructs increased linearly with the
number of Venus molecules (Fig 2A). Micro-time data was used to
calculate the TRA (Fig 2B) of homogenates prepared from cells
expressing V1–V6. The V1 anisotropy decayed as a single-
exponential (t=15.360.8 ns). Like V1, V2–V6 also had a slow
decay component (t.15 ns), as well as additional fast decay
components occurring primarily within the first 2 ns. The
similarity between the V1 decay constant and the rotational time
constant of purified Venus (16.460.6 ns) [42] indicates that V1 is
a monomer in solution. The additional fast depolarization
observed for V2–V6, much faster than monomer rotation, is the
hallmark of homo-FRET between fluorescent proteins [10,11].
While the amplitude of these fast anisotropy decay components is
a function of the number of Venus molecules exchanging energy
by FRET [10,11], the similarity between the V4–V6 anisotropy
decay curves reveals a major limitation for using homo-FRET
alone to estimate subunit stoichiometry in a complex with four or
more subunits.
The same micro-time data was also used to calculate the lifetime
of Venus in these control constructs (Fig 2C). The lifetime of
Venus was 3.160.0 ns, similar to values measured previously
(3.0360.01 ns) [42], and its lifetime was not appreciably altered by
concatenation or by homo-FRET. Because the photon count rate
emitted from a molecule depends on the molecule’s lifetime, this
observation also indicates that subsequent FCS based brightness
analysis will not be significantly influenced by homo-FRET. Thus,
the primary source of intensity fluctuations in the FPFA
experiments described here should be the diffusion of Venus-tagged
molecules in and out of the excitation volume.
Macro-time data was used to calculate the cross-correlation
between photons detected in parallel and perpendicular channels
[39]. Cross-correlations for Venus concatemers were all well fit
using a single-component 3-dimensional Gaussian model [17], and
these fits were used to derive the correlation time and the average
number of diffusing molecules in the observation volume. The
later was used to normalize the photon count rate to calculate
molecular brightness as mentioned earlier. Figures 2D & E show
the correlation time and molecular brightness obtained for each
concatemer. A systematic increase in correlation time was
observed as the number of Venus molecules per concatemer
increased, but as expected, correlation time was not very sensitive
to changes in mass. Molecular brightness also increased with the
number of Venus molecules in a concatemer, but unlike the
correlation time, molecular brightness was linearly proportional to
the number of Venus molecules in a concatemer (Fig 2E). Thus,
while changes in correlation time may serve as an indicator of
complex formation, the ratio of the brightness of a construct and
the brightness of a Venus monomer can directly reveal the number
of Venus molecules in a construct. This normalized brightness
analysis can potentially be used to specify the number of
fluorophore-tagged subunits in a protein complex, as will be
shown later when FPFA is used to investigate the holoenzyme
structure of Venus-tagged CaMKII.
Because FPFA can measure homo-FRET, it should be able to
detect structural changes that FCS cannot. To test this capability,
FPFA was performed on three different Venus dimers, V5V (the
V2 construct), V17V and V32V, where 5, 17 and 32 amino acids
linkers separate Venus molecules respectively. TRA analysis
revealed that these 3 dimers all had fast decay components
indicative of homo-FRET [11] (Fig 2F). The decay rate of these
fast components should be proportional to the FRET transfer rate,
itself a function of the distance between Venus molecules [11].
Consistent with this, the anisotropy of V5V decayed fastest while
V32V decayed the slowest. In contrast, the correlation times and
brightness of V5V, V17V, and V32V were comparable (Fig 2F
inset).
FPFA Studies of CaMKIIa Holoenzyme in vitro
To measure the number of subunits in the CaMKIIa
holoenzyme with FPFA, cells were transfected with DNA encoding
Venus-CaMKIIa (V-CaMKIIa). Previous studies have shown that
tagging the N-terminus of CaMKII with GFP does not alter its
catalytic activity, auto-phosphorylation, or the ability of the kinase
to assemble [36,43]. Furthermore, we have shown that V-
CaMKIIa expressed in neurons undergoes a change in anisotropy
correlated with calcium influx through NMDA receptors [10].
The next day, transfected cells were harvested and homogenates
prepared for FPFA. Supernatants from homogenates of cells
expressing V-CaMKIIa had a normalized brightness of 10.261.3
(n=5, mean6SD) (Fig 2A). FPFA experiments were repeated
using V-CaMKIIa[TT305/306DD] a mutant that cannot bind
Ca
2+/CaM to determine if the auto-inhibited holoenzyme is also a
decamer. V-CaMKIIa[TT305/306DD] had a mean normalized
brightness of 10.761.3 (n=5, mean6SD). These values were not
statistically different (paired Student’s t test, P=0.2987). Nearly an
identical number of subunits was determined using electron
microscopy to count catalytic-domain protrusions on wild-type
holoenzyme isolated from rat forebrain (predominantly CaMKIIa)
[24]. Thus, in solution there is on average 10 V-CaMKIIa
subunits in the auto-inhibited holoenzyme.
The correlation time for V-CaMKIIa holoenzyme was
1.260.1 ms (mean6SD, n=5) and for V-CaMKIIa[TT305/
306DD] it was 1.360.1 ms (mean6SD, n=5) (Fig 3B). As
expected for a large holoenzyme, these samples diffused much
slower than the Venus monomer (Fig 2D). TRA analysis revealed
a fast homo-FRET component for V-CaMKIIa and V-CaM-
KIIa[TT305/306DD] indicative of catalytic domain pairing
(Fig 3). Hetero-FRET analysis was used to confirm the existence
of catalytic domain pairing in the CaMKIIa holoenzyme, as well
as to measure the FRET efficiency detected between fluorescent
protein tagged catalytic domains. Cells were transfected with DNA
constructs encoding CaMKIIa tagged on the catalytic domain
with either Cerulean [44] acting as a FRET donor, or Venus [38]
as a FRET acceptor. Cells transfected with Cerulean-CaMKIIa
(C-CaMKIIa) & free Venus monomers were used as a negative
FRET control, while cells transfected with C5V, a construct with a
Cerulean donor tethered to a Venus acceptor using a 5 amino-acid
linker [45,46], was used as a positive FRET control. FRET
efficiency values and the fraction donor were measured the
following day from live cells using E-FRET microscopy [47,48].
Cells transfected with C-CaMKIIa & V-CaMKIIa had FRET
efficiencies that increased linearly as the donor fraction decreased
(Fig 3D). A linear relationship between the observed FRET
efficiency when plotted as a function of the donor fraction is
indicative of FRET occurring between 1 donor and 1 acceptor
[49], and suggests that catalytic domains form pairs within the
holoenzyme structure in living cells. The FRET efficiency (the y-
intercept when the donor fraction is zero) between fluorescent
protein-tagged CaMKIIa catalytic domains was 39.460.8%,
while the FRET efficiency for our negative control was
5.660.8%. The FRET efficiency for the C5V positive control
was 48.963.8% (mean6SD, n=34 cells), and C5V’s fraction
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covalently linked to one acceptor.
FPFA Measurements in Cells
To measure the number of subunits that comprise the CaMKIIa
holoenzyme in living cells using FPFA required expressing V-
CaMKIIa atlowenoughconcentrations todetect fluctuation,while
also allowing sufficient time for protein expression, Venus matura-
tion, and holoenzyme assembly. Because the amount of protein
expressionat24hourscouldbecontrolledbytitratingtheamountof
RNA used in a transfection [50], RNA encoding V-CaMKIIa was
usedforlivecellFPFA.Additionally,thelaserpowerforlivecellFPFA
was reduced to 6 mW to prevent bleaching. The TRA of V-
CaMKIIa in cells (Fig 4A) was similar to the signals observed in
solution being more depolarized than the V1 monomer, but less
depolarized than the V3 Venus trimer (Fig 3C), and together with
hetero-FRET experiments in cells (Fig 3D) indicates that catalytic
domainpairingoccursincellsaswellasinsolution.Thebrightnessof
cellstransfectedwithRNAencodingtheV1–V6controlsareshownin
figure4B.Incells,thebrightnessoftheseconcatemerswasstilllinear
with the number of Venus molecules with the exception that V1
showed a slightly elevated value. This can be attributed to
endogenous autofluorescence. The V2–V6 brightness values were
wellfittoalinearmodelsoalinearinterpolationwasusedtocalculate
normalizedbrightnessofVenus-CaMKIIaholoenzymeincells.The
normalized brightness for V-CaMKIIa in cells was 11.961.2
(mean6SD, n=11cells) (Fig 4B). Surprisingly, the holoenzyme in
cells had approximately 2 more subunits than holoenzyme in
solution. The variance of this measurement was twice as large as
the 95%prediction bands of the linear fit of our controls, suggesting
thatin cellsV-CaMKIIahasonaverage12subunits,butrangesfrom
8–14 subunits.
Figure 2. FPFA Validation. (A) Western blot of homogenates prepared from cells expressing Venus monomers (V1), dimers (V2), trimers (V3),
tetramers (V4), pentamers (V5) and hexamers (V6) using a GFP specific antibody. Red boxes outline the immuno-reactive components corresponding
to the expected molecular weights of these concatemers. (B) Time-resolved anisotropy (TRA) recorded from homogenates prepared from cells
expressing V1–V6. The data are plotted on a semi-log scale to highlight the single exponential decay of V1 as compared to the multi-exponential
decays of V2–V6. (C) Fluorescence lifetime decays of V1–V6. (D) The correlation times for V1–V6 are plotted. Bars represent mean values for each
construct (n=4). The excitation power used was 9.0 mW. (E) The brightness values for V1–V6 are plotted as a function of the number of Venus
molecules in each construct. Red line indicates fit to a linear model with dashed blue lines indicating the 95% confidence bands. (F) TRA of three
Venus dimers, V5V, V17V, and V32V, where 5, 17, and 32 indicates the number of amino-acids in the linker separating the two fluorophores. The TRA
of Venus monomers are also shown to highlight that all three of these constructs had a fast decay component due to homo-FRET. Insets show the
correlation times and brightness of these samples (mean6SD, n=3).
doi:10.1371/journal.pone.0038209.g002
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FPFA was validated using two sets of controls. The first set
consisted of 6 Venus concatemers. FPFA readily differentiated
these molecules by their brightness, and to a limited extent by their
anisotropy and correlation time (Fig 2). Importantly, brightness
analysis unambiguously determined the number of Venus
molecules in each construct (Fig 2E). The second set of controls
consisted of 3 Venus dimers separated by different length amino-
acid linkers. Here, based on different fluorophore separation
distances, anisotropy could differentiate between these molecules
(Fig 2F). Thus, FPFA can detect subtle structural differences based
on homo-FRET, changes in mass and hydrodynamics using
correlation times, while simultaneously monitoring the number of
fluorophores in a complex using brightness analysis.
Figure 3. FPFA of CaMKIIa holoenzyme. (A) The normalized brightness for V-CaMKIIa holoenzyme, and mutant that cannot bind Ca
2+/CaM. Bars
representthemeanswithn=5.Theexcitationpowerusedwas10.2 mW.(B)ThecorrelationtimesforsamplesinpanelA.(C)AverageTRAforsamplesin
panel A. TRA traces for Venus monomers (V1) and Venus trimers (V3) from figure 2B are overlaid as a reference, and to illustrate that the Venus-tagged
catalytic domains in V-CaMKIIa produce an anisotropy signal most consistent with Venus-dimers. (D) Hetero-FRET analysis of CaMKIIa catalytic domain
pairingin livingcells.Cellswere transfectedwith DNAconstructsencodingCaMKIIataggedonthecatalyticdomainwitheitherCeruleanorVenus.Cells
transfectedwithCerulean-CaMKIIa&freeVenusmonomerswereusedasanegativeFRETcontrol.CellstransfectedwithC5VwasusedasapositiveFRET
control.Eachpointis theaverageFRETefficiencyandfractiondonorvaluemeasuredfor anindividualcell. Dashedlinesarelinearfits.
doi:10.1371/journal.pone.0038209.g003
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PLoS ONE | www.plosone.org 6 May 2012 | Volume 7 | Issue 5 | e38209Figure 4. FPFA of V-CaMKIIa expressed in HEK cells. (A) Average TRA for V-CaMKIIa (Black) holoenzyme in cells. TRA traces for Venus
monomers (V1, Yellow) and Venus trimers (V3, Green) expressed in HEK cells are also plotted as a reference, and to illustrate that the Venus-tagged
catalytic domains in V-CaMKIIa produce an anisotropy signal most consistent with Venus-dimers. The excitation power used was 6 mW. (B) The
brightness values for V1–V6 expressed and measured in HEK cells are plotted as a function of the number of Venus molecules in each construct. Each
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warrant consideration. First, polarization artifacts can be avoided
by measuring the cross-correlation of parallel and perpendicular
polarized detectors [39]. Because the molecular brightness of
V5V, V17V and V32V yielded comparable values (although their
time-resolved anisotropies were visibly different) this conclusion is
supported (Fig 2F). A second potential source of error is the impact
of flickering on brightness measurements [19]. Because fluorescent
protein flickering has not been observed with two-photon
excitation, flickering should not impact FPFA measurements as
implemented here. This conclusion is supported by the observed
linear relationship between molecular brightness and the number
of Venus molecules in a concatemer (Fig 2E). Finally, for live cell
FPFA measurements, auto-fluorescence can corrupt brightness
measurements [16,17]. The apparent brightness of a sample with
more than one fluorophore species is thought to be a nonlinear
function weighted by the abundance of each fluorescent species
multiplied by the square of its brightness [18,51] (see discussion in
Materials and Methods). In typical live cell experiments the
fluorophore tag and the wavelength used to excite it are both
selected to maximize the fluorescent signal of the fluorophore, and
to minimize cellular auto-fluorescence. Under these conditions,
the brightness of the sample will typically be much brighter than
the brightness of auto-fluorescent species. Even if the concentra-
tion of these dim auto-fluorescent species are significantly higher
than the concentration of the fluorophore-tagged species, if a
sample has or can be tagged with multiple copies of the
fluorophore, eventually the contribution of auto-fluorescence to
the apparent brightness of the sample will become negligible. This
was observed in figure 4B for Venus concatemers.
Using FPFA we show that in cells V-CaMKIIa holoenzyme has
on average 12 subunits (Fig 4B), with its catalytic-domains
arranged as pairs (Fig 4A). The pairing of catalytic domains in
the holoenzyme was previously observed in hippocampal neurons
using anisotropy measurements [10], and this structural feature of
the auto-inhibited holoenzyme was confirmed using hetero-FRET
measurements in cells (Fig 3D). It is unlikely that attached
fluorescent proteins caused this dimerization because 1) a
monomeric form of Cerulean and Venus were used in all
experiments [41], 2) homo-FRET was not observed between
Venus monomers (V1, Figs 2B, & 4A), and 3) isolated non-tagged
catalytic domains formed dimers in solution [30].
It is likely that these dimers exist specifically in the postulated
auto-inhibited extended form of the CaMKIIa holoenzyme [35]
because homo-FRET between Venus-tagged catalytic domains
was observed in the V-CaMKIIa[TT305/306DD] construct
(Fig 3C). As mentioned previously, the TT305/306 to DD305/306
mutations are expected to disrupt the compact auto-inhibited
holoenzyme structure [35] but also block the activation of the
enzyme by preventing Ca
2+/CaM binding [36]. Thus, our FPFA
data supports the postulated Ca
2+/CaM accessible auto-inhibited
holoenzyme structure, but with catalytic domains organized as
pairs. Presumably, when catalytic domains un-dock from the
association domain core they reorganize to form dimers.
Like in living cells, catalytic domain pairing was also observed in
freshly prepared homogenates (Fig 3C). In contrast, the number of
subunits in the holoenzymes was reduced from 11.961.2 in cells to
10.261.3 in homogenates. Thus, catalytic domain pairing as
observed by homo-FRET occurs in cells as well as in vitro and
persists despite a reduction in holoenzyme subunits stoichiometry.
This would be expected if the reduction in subunits represent a loss
of a pair of subunits from the holoenzyme with their paired
catalytic domains, rather than a loss of two independent subunits.
This type of paired subunit organization has been previously
proposed based on subunit stoichiometry distributions from
electron microscopy imaging of native holoenzyme [24].
An implicit assumption of using brightness analysis to measure
the number of subunits in a CaMKII holoenzyme is that only
subunits tagged with a fluorophore are incorporated into a
complex. This assumption may not always be warranted,
particularly for cells that express a high level of non-tagged
endogenous subunits. Under these conditions it is prudent to
interpret normalized brightness as a lower limit for the number of
subunits in a complex. In these studies for Venus-CaMKIIa
expression in HEK cells this is unlikely to be a problem because
the CaMKII subunit stoichiometry predicted by FPFA analysis
was in good agreement with estimates based on non-tagged native
holoenzyme [23,24]. Nonetheless, a conservative interpretation of
our data would conclude that in cells CaMKIIa holoenzyme
typically has $12 subunits.
The impact of fluorophore-tagging must be considered when
interpreting structural findings based on fluorescence. Here FPFA
detected 2 distinct V-CaMKIIa protein interactions which were
previously observed using untagged-CaMKII. First, in cells V-
CaMKIIa subunits assembled to form a dodecamer (Fig 4B), a
value similar to in vitro estimates using native holoenzyme [23,24],
and in vivo measurements based on GFP-tagged CaMKIIa
translocation [25]. Second, catalytic domains were arranged as
pairs in the holoenzyme (Figs 3C & 4A), consistent with homo-
FRET [10], hetero-FRET (Fig 3D), and ultra-centrifugation
studies using untagged catalytic domains [30]. Thus, it is unlikely
that Venus-tagging caused or significantly perturbed these
interactions.
It is worth comparing the relative merits of CaMKIIa
holoenzyme structural studies inside living cells based on
considering only hetero-FRET data (Fig 3D), only homo-FRET
data ([10], and Fig 4A), as compared to considering both homo-
FRET and brightness analysis from FPFA (Fig 4A & B). Hetero-
FRET analysis (Fig 3D) readily demonstrated that fluorescent
protein-tagged CaMKIIa catalytic domains were in close prox-
imity. The ensemble FRET efficiency for the 171 cells transfected
with C-CaMKIIa and V-CaMKIIa was 25.267.9%, significantly
higher than our negative control. Nonetheless, FRET efficiencies
ranging from 0 to 40% were observed depending on the relative
expression of Cerulean- and Venus-tagged CaMKIIa subunits.
Thus, if the fraction donor were not simultaneously measured, as is
often the case for many FRET approaches, interpretation of this
hetero-FRET data would be problematic. For example, our
interpretation of CaMKIIa hetero-FRET in cells, as energy
transfer between paired donors and acceptors with a FRET
efficiency of 39.460.8% was based on modeling how the FRET
efficiency changed from cell to cell as a function of the fraction
donor. While we feel this interpretation is compelling, we also note
that these experiments cannot differentiate between holoenzyme
structures having a single set of paired subunits, and various other
possible configurations comprised of multiple sets of paired
point represents a single cell, and at least 3 cells were measured for each Venus concatemer. Note that the V1 brightness was slightly elevated,
presumably due to endogenous autofluorescence. Red dashed line indicates fit to a linear model for V2–V6 with dashed blue lines indicating the 95%
confidence bands. The average brightness and normalized brightness of V-CaMKIIa (Blue squares, mean6SD, n=11 cells) is plotted on the main
graph with error bars indicating two standard deviations.
doi:10.1371/journal.pone.0038209.g004
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FRET, perhaps as a result of over expression.
Homo-FRET analysis (Fig 4A) could also readily detect energy
transfer between Venus-tagged catalytic domains, again indicating
that in cells Venus-tagged catalytic domains are in close proximity
to other Venus-tagged catalytic domains. Based on the amplitude
of V-CaMKIIa’s fast anisotropy decay component, compared to
the anisotropy decays of Venus monomer and trimer controls, it is
most likely that V-CaMKIIa’s catalytic domains are organized as
pairs [10]. Like the previous hetero-FRET analysis, homo-FRET
analysis alone cannot differentiate between a holoenzyme struc-
ture having a single set of paired subunits, and configurations
comprised of multiple sets of paired subunits. One advantage of
homo-FRET over hetero-FRET in that only a single fluorescent
protein tagged CaMKII subunit, V-CaMKIIa, was needed for
these measurements. Thus, possible errors related to the relative
expression of donor and acceptor-tagged subunits are eliminated.
Both homo- and hetero-FRET analysis are susceptible to false
positive FRET signals due to over expression of fluorophore-
tagged subunits in cells. One advantage of homo-FRET analysis of
data collected by FPFA is that the possibility of false positives is
almost completely eliminated. For soluble fluorophores, non-
specific FRET typically requires concentrations greater than
1 mM [4,52]. With the FPFA instrumental design reported here
this would correspond to having in excess of 210,000 Venus
molecules in the 0.35 fl observation volume of our microscope. At
these high concentrations fluorescence intensity fluctuations (due
to individual fluorophores moving in and out of the observation
volume) are too small relative to the average fluorescence intensity
to be measured [17]. For this reason, FCS and FPFA measure-
ments, by necessity, are limited to samples with concentrations
much less than 1 mM( ,210 molecules). Furthermore, to avoid
TCSPC pile-up errors [13] in time-resolved anisotropy measure-
ments, samples for FPFA was further restricted to those with
count-rate less than 100,000 cps. Within these limits, the
maximum number of Venus molecules in the observation volume
that we could measure is ,120 (,570 nM), but was typically
much smaller. For example, in figure 1D the number of Venus
molecules in the observation volume was ,65. Thus, observing
non-specific FRET in a FPFA experiment is highly unlikely.
Another major advantage of FPFA analysis over both hetero- and
homo-FRET analysis is that FPFA simultaneously measures
normalized brightness. Thus we can deduce that the dimeric
homo-FRET signal we observed in cells for V-CaMKIIa (Fig 4A)
was coming from protein complexes having on average at least 12
subunits (Fig 4B). This observation eliminates the possibility that
tagging CaMKIIa on its N-terminus (catalytic domain) prevented
holoenzyme oligomerization via its association domain. We
conclude that the advantages of being able to simultaneously
measuring homo-FRET, brightness, and correlation time to study
protein interactions in living cells justifies the use of FPFA over
other FRET approaches, and in addition to being a useful tool for
understanding the structure of the CaMKII holoenzyme; FPFA
can also be used to study protein interactions in other complexes
as well.
Materials and Methods
Cell Culture, Transfection and Homogenate Preparation
HEK 293 cells (ATCC) were cultured as a monolayer in a T-75
Flask (Corning) in a humidified incubator containing 5% CO2 in
air at 37uC in High Glucose DMEM media containing L-
Glutamine, sodium pyruvate and 10% fetal bovine serum (all from
Gibco). A day prior to FPFA measurement, cells were resuspended
using TrypLE Express (Invitrogen) and washed with DPBS (with
calcium and magnesium, Mediatech). For in vitro measurements,
plasmid DNA encoding Venus-tagged constructs (typically 1 mg/
250,000 cells) were transfected into the cells using electroporation
(Digital Bio/BTX MicroPorator). Transfected cells were plated on
60 mm culture dishes (Falcon) and incubated overnight. On the
following day, cells were harvested and lysed using passive lysis
buffer (Promega). Homogenates were centrifuged at 100,0006g
for 1 hour to remove membranes and particulate matter.
Supernatants were diluted for FPFA to yield a photon count rate
between ,20,000 cps (.256 the dark count rate) and
,100,000 cps (to avoid TCSPC pile-up artifacts [13]). The
clarified homogenates were then loaded into 35 mm glass bottom
dishes (MatTek) and micro- and macro-times were measured by
FPFA the same day. For live-cell measurements, cells were
transfected with RNA encoding Venus-tagged constructs since the
amount of protein expression after 24 hours could be controlled by
titrating the amount of RNA used during transfection, typically
around 500 mg of RNA/250,000 cells was used. Transfected cells
were plated on 35 mm glass bottom dishes and incubated
overnight in phenol-red free DMEM media and FPFA was
measured the next day.
Molecular Biology and Immunoblot Analysis
DNA clones encoding V1 (Addgene ID 277794), V2/V5V
(Addgene ID 29423), V3 (Addgene ID 27814), V4 (Addgene ID
29425), V5 (Addgene ID 29426), V6 (Addgene ID 27813), V17V
(Addgene ID 29424), V32V (Addgene ID 29561), and V-
CaMKIIa (Addgene ID 29428) are available from Addgene
(http://www.addgene.org/Steven_Vogel#). DNA clones encod-
ing V-CaMKIIa [TT305/306DD], and C-CaMKIIa, were
generated as follows: Sense (59-GGAGCCATCCTCGACGA-
CATGCTGGCCACCAGG-39) and antisense (59-
CCTGGTGGCCAGCATGTCGTCGAGGATGGCTCC-39)
primers were used to perform site directed mutagenesis PCR (as
previously described [10]) to generate V-CaMKIIa[TT305/
306DD]. Note that the mutated bases are underlined in the
primer sequences. C-CaMKIIa was generated by excising the
open reading frame of mouse CaMKIIa from V-CaMKIIa
(Addgene ID 29428) and inserting it into a Sal1/BamH1 digested
Cerulean C1 (Addgene ID 27796). The resulting C-CaMKIIa
construct was confirmed by sequencing. For RNA transfection,
DNA encoding full length V-CaMKIIa was excised and inserted
into the Prn2 vector [50]. This clone was digested using Not-1 and
the linearized plasmid was used to generate cRNA using a
mMachine mMessage RNA kit (Ambion).
Immunoblot analysis. HEK 293 cells were transfected with
plasmid DNA encoding the V1–V6 constructs. Cells (80–100%
confluent) expressing Venus concatamers were scrapped off the
dish, washed twice with PBS, and pelleted. The pellet was then
lysed in denaturing Laemmli buffer (BioRad) with 1% SDS and b-
Mercaptoethanol and heated to 90 Cu for 10 minutes. Cell debris
was removed by centrifugation (20,0006g for 10 mins), and 20 ml
of the solution was loaded into a precast gradient SDS PAGE gel
(4–20%; BioRad). Immunoblotting with a GFP specific antibody
(NeuroMab Anti-GFP N86/8) was performed as previously
described [42].
Fluorescence Polarization and Fluctuation Analysis
Experimental Setup
An 80-MHz, 200-fs mode locked Ti:sapphire laser (Coherent
Chameleon Ultra-2) was tuned to 950 nm to provide pulsed two-
photon excitation. The power of the laser beam was adjusted using
a variable attenuator consisted of a half-wave plate and a Glan-
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expanded using a spatial filter system (KT310, Thorlabs), and then
passed through a near-IR linear polarizer (100,000:1 extinction
ratio, Thorlabs) to enter the back port of a Zeiss Axio Observer
microscope. A multiphoton short-pass dichroic beamsplitter
(FF670-SDi01-25636, Semrock) was used to reflect the excitation
beam to a Zeiss 63621.2 NA water objective (back aperture
slightly overfilled) that focused the beam to a diffraction-limited
spot (, 0.4 mm in diameter). Fluorescence from the observation
volume in the sample was filtered through a BG39 filter (to block
residual near-IR photons), a high throughput band-pass filter
(FF01-540/50–25, Semrock), and then guided to a polarizing
beam splitter (Thorlabs) that was augmented with two orthogo-
nally oriented linear polarizers (Thorlabs) to increase the
extinction ratio. At the beam splitter, parallel and perpendicular
emitted photons were separated and focused onto two HPM-100-
40 hybrid detectors (Becker & Hickl). The dark count rate for these
detectors was typically 400–750 cps at room temperature. Photons
detected by each detector were processed by a SPC-132 TCSPC
card (Becker & Hickl). The SPC-132 recorded both micro- and
macro-time for each parallel and perpendicular detected photon.
For synchronization between excitation pulses and detected
photons, a small fraction of the excitation beam was extracted
and focused onto a fast photodiode that was powered by battery to
avoid crosstalk. Note that all optics used in the excitation pathway
was selected to minimize group delay dispersion.
SPCM software (Becker & Hickl) running in FIFO mode was
used for data acquisition and to calculate time-resolved fluores-
cence and auto-/cross-correlation functions from measured micro-
and macro-time data, respectively. Excitation power was kept low
(typically 10.2 mW in vitro and 6 mW in living cells) to avoid
bleaching during acquisition (,120 s in vitro and 20 s in living
cells). For each homogenate, three to five replicate measurements
were performed and these were averaged for each point. For live-
cell measurements ten to fifteen replicate measurements were
averaged for each cell. All measurements were performed at room
temperature.
Time Resolved Anisotropy and Lifetime Analysis
Time-resolved anisotropy was calculated based on fluorescence
decay of parallel and perpendicular channels using the following
equation [10,11]:
r(t)~
I==(t){g:I\(t)
I==(t)z2g:I\(t)
ð1Þ
where I//(t) and IH(t) are fluorescence intensity of parallel and
perpendicular channels (dark noise subtracted) respectively, and g
is the instrument correction factor which for our microscope had a
value of 1 as determined by calibration using fluorescein tail
fitting.
The total time-dependent fluorescence intensity decay or lifetime
was calculated using the following relationship [13].
I(t)~I==(t)z2g:I\(t) ð2Þ
Polarized Fluorescence Fluctuation Analysis
For FPFA, a cross-correlation curve is fitted to a single
component three-dimensional Gaussian function [17] G(t)t o
estimate the values ,N., the average number of fluorescent
molecules in the excitation volume, and tD, the correlation time,
the average time that a molecule spends in the detection volume:
G(t)~
c
SNT
1
1z(t=tD)
1
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1z(v=z)
2(t=tD)
q ð3Þ
Where v and z, are the radial and axial beam waists respectively,
and the constant c has a value of 0.35 for a two-photon three-
dimensional Gaussian PSF [17].
The molecular brightness g is the average number of photon
emitted per second per molecule (cpsm):
g~
SkT
SNT
ð4Þ
where ,k. is the average photon count rate recorded during data
acquisition.
The normalized brightness, r, of a Venus-tagged protein
complex was determined by dividing the molecular brightness
(gcomplex) of a complex composed of Venus-tagged subunits, by the
molecular brightness of a Venus monomer (gVenus):
r~
gcomplex
gvenus
ð5Þ
Note that gcomplex and gVenus should be measured using similar
conditions (primarily using the same laser excitation power, filters,
and optics), and that gVenus can be measured by running a Venus
monomer control. In cells, where auto-fluorescence was an issue,
the normalized brightness was calculated using the measured slope
(m) and y-intercept (b) of the linear portion of the V1–V6
brightness curve:
r~
gcomplex
m
{
b
m
ð6Þ
With two-photon excitation the relationship between correlation
time tD and the diffusion coefficient D is given by [53]:
tD~
v2
8D
ð7Þ
Calibration
The instrument correction factor g for calculating time-resolved
anisotropy (equation 1) was measured using tail-fitting [11] of
fluorescein samples and found to be 1. At high pH, fluorescein has
a constant quantum yield and its diffusion coefficient D is
300 mm
2/s at room temperature [17]. Thus, equation 7 can be
used to estimate the value of v (at a specific excitation power) by
measuring fluorescein’s correlation time (at the same power). For
example, with D=300 mm
2/s, and a measured correlation times
of 74.869.3 ms (n=3), the value of v was 424626 nm with
10.2 mW excitation power (at 950 nm). The ratio v/z (equations
3 and 4) was measured by global fitting (to equation 3) of cross-
correlation curves obtained from known dilutions of fluorescein. In
this calibration it is assumed that with constant excitation power
for all fluorescein dilutions, only the value ,N. will change with
dilution. At 10.2 mW excitation power the v/z ratio was
0.1560.00, and taken together with our estimate for v predicts
a z value of 2.860.2 mm. The validity of this calibration procedure
was confirmed by measuring the diffusion coefficient of Venus
monomers under identical conditions. Using v=424 nm, and v/
z=0.15 the measured correlation time for Venus monomers with
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sponds to a diffusion coefficient for Venus monomers in solution of
6563 mm
2/s (n=3) in good agreement with the diffusion
coefficient measured for GFP [51]. Because fluorescein was poorly
excited with 6 mW excitation power at 950 nm, calibration for
live cell FPFA used a slightly different procedure. Global fitting of
cross-correlation curves obtained from dilutions of Venus mono-
mers were used to measure the ratio v/z (0.1060.00), as well as
the correlation time of Venus monomers (299665 ms, n=3).
These values indicated that with 6 mW excitation power
v=367685 nm and z was 3.760.9 mm. Note that these values
had large errors because of the low excitation power. We used v
and z values measured at 6 and 10.2 mW excitation power to
determine if the two-photon observation volume changed appre-
ciably with increased excitation power. The two-photon observa-
tion volume (V) at any specific excitation power can be calculated
using the following equation [17]:
V~
p
3= 2v2z
8
ð8Þ
Accordingly, the observation volume with 10.2 mW excitation
power was 0.35 fl, only slightly larger than the volume measured
at lower power (6 mW, 0.34 fl). Note that these volumes, and the
value of ,N. from a FPFA measurement can be used to calculate
the concentration of Venus or of Venus-tagged protein complexes,
a key factor for determining if non-specific FRET (due to
molecular crowding) can occur.
Hetero-FRET Measurements
DNA encoding CaMKIIa tagged on the catalytic domain with
Cerulean [44] acting as a FRET donor, and Venus [38] as a
FRET acceptor were transfected into HeLa cells (ATCC). Cells
transfected with Cerulean-CaMKIIa & free Venus monomers
were used as a negative FRET control, and cells transfected with
C5V [45] was used as a positive control. Images were acquired on
an automated wide-field microscope and FRET analysis was
performed using the E-FRET method [48] calibrated with
Cerulean and Venus FRET standards [45]. Each point is the
average FRET efficiency and fraction donor value measured for
an individual cell. Dashed lines are linear fits. A linear relationship
between the observed FRET efficiency (Eobs) when plotted as a
function of the fraction donor (p) indicates that FRET is only
occurring between 1 donor and 1 acceptor [49]. This linear
relationship can be understood as follows: If CaMKII subunits
form random pairs based only on their abundance, then if p is the
fraction of Cerulean-tagged CaMKII subunits in the population,
then (1-p) will be the fraction of Venus-tagged CaMKII subunits in
the population. The random pairing of Cerulean- and Venus-
tagged catalytic domains can be modeled using a binomial
distribution. In a population the fraction of Cerulean-tagged
CaMKII subunits paired with other Cerulean-tagged CaMKII
subunits will be p
2, and each of the 2 Cerulean molecules in these
pairings will have a FRET efficiency of zero because they are both
not pared with a Venus acceptor. Similarly, the fraction of Venus-
tagged CaMKII subunits paired with another Venus-tagged
CaMKII subunits will be (1-p)
2, but because these pairs lack
donors, they have no direct impact on the FRET efficiency of the
population. Finally, the fraction of Cerulean-tagged CaMKII
subunits paired with Venus-tagged CaMKII subunits will be 2p(1-
p), and because each has a single donor (and acceptor), they will
each have a FRET efficiency of E. Thus the observed ensemble
FRET efficiency for the population Eobs as a function of the
fraction donor (p) will be:
Eobs p ðÞ ~
2p 1{p ðÞ :E
2p2z2p(1{p)
~ 1{p ðÞ :E ð9Þ
Note, that Eobs is a linear function of p, and that the slope and y-
intercept (when p=0) are both equal to the FRET efficiency
between a single donor and acceptor.
The Impact of Autofluorescence on Brightness
Measurements for Live Cell FPFA
For live cell FCS measurements, auto-fluorescence and other
background light sources can impact on brightness measurements
[16,17,18,51]. In addition to the fluorophore of interest, endog-
enous fluorophores can also emit photons resulting in an altered
apparent brightness. This problem can also occur for FPFA based
brightness measurements. Corrections for two different types of
background signals have been described, these are: 1. Background
signals that only alter the photon-count rate, and 2. Background
fluorescence from endogenous fluorophores that fluctuate. For
background signals that only alter the photon-count rate the
apparent molecular brightness (gapp) of the sample is [16,18]:
gapp~g: SkT{SkBT ðÞ
2
SkT
2 ð10Þ
Where g is the brightness of the exogenous fluorophore, ,k. is
the average measured count rate (sample plus background), and
,kB. is the average measured count rate of the background. The
apparent brightness of a sample with fluctuating endogenous
fluorophores is [18,51]:
gapp~
g2SNTz
P
b
g2
bSNbT
gSNTz
P
b
gbSNbT
ð11Þ
Where g and ,N. are the molecular brightness and the average
number of exogenous fluorophore molecules in the observation
volume, and gb and ,Nb. are the molecular brightness and the
average number of molecules in the observation volume of the bth
fluorescence background species. In living cells it is possible that
both of these types of background signals can adversely contribute
to the apparent brightness. Furthermore, the relative impact of
these types of background signals on the apparent brightness is
rarely known. Moreover, many of the factors in equation 11 are
either difficult to measure or are themselves unknown, and it is
worth noting that the validity of these corrections has not been
rigorously tested. An alternative empirical strategy for interpreting
the apparent brightness of a complex composed of FP-tagged
subunits, in terms of subunit stoichiometry, is to compare an
unknown samples brightness to the measured brightness of a series
of FP-concatemers expressed in the same cell type, such as the use
of the V1– V6 series used in this study. The underlying assumption
for this calibration strategy is that the brightness, abundance and
fluctuation behavior of the sources of cellular background signals
are not altered by the expression of different FP-tagged constructs.
Under ideal conditions, experimental samples will have brightness
values falling within the range of a control set (1–6 subunits in this
instance). Under these conditions control brightness values can be
used directly as a standard curve to interpret the brightness of an
unknown. For samples with an apparent brightness greater than
the largest concatemer in a control set (in this example those with
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estimated by extrapolating brightness values based on the standard
brightness curve. While extrapolations beyond control values is not
ideal, by using proper error propagation [54] errors in interpre-
tation can be minimized.
Curve Fitting and Statistics
IGOR Pro software (Vs 6.22) was used for standard and global
fitting of time-resolved anisotropy, cross-correlation curves, and
linear fits for brightness controls. GraphPad Prism 5 was used to
calculate means and standard deviations (SD). Values are
presented throughout the text as mean6SD, deviations of 60.00
indicate a value of less than 0.005, while deviations of 60.0
indicate a value of less than 0.05. GraphPad Prism was also used to
calculate Student’s t-test, which was paired and two-tailed.
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